[1]刘在波,修文娟.背阔肌皮瓣联合假体在乳腺癌改良根治术后乳房重建中的应用[J].医学信息,2019,32(02):127-128.[doi:10.3969/j.issn.1006-1959.2019.02.036]
 LIU Zai-bo,XIU Wen-juan.Application of Latissimus Dorsi Flap Combined with Prosthesis in Breast Reconstruction after Modified Radical Mastectomy for Breast Cancer[J].Journal of Medical Information,2019,32(02):127-128.[doi:10.3969/j.issn.1006-1959.2019.02.036]
点击复制

背阔肌皮瓣联合假体在乳腺癌改良根治术后乳房重建中的应用()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年02期
页码:
127-128
栏目:
临床研究
出版日期:
2019-01-15

文章信息/Info

Title:
Application of Latissimus Dorsi Flap Combined with Prosthesis in Breast Reconstruction after Modified Radical Mastectomy for Breast Cancer
文章编号:
1006-1959(2019)02-0126-002
作者:
刘在波修文娟
山东省烟台市海阳市人民医院普外二科,山东 海阳 265100
Author(s):
LIU Zai-bo1XIU Wen-juan2
Department of General Surgery1,Subject Two,Department of Pediatrics2, Haiyang People's Hospital, Yantai City,Haiyang 265100,Shandong,China
关键词:
乳腺癌背阔肌皮瓣假体乳腺改良根治术乳房重建
Keywords:
Breast cancerLatissimus dorsi flapProsthesisModified radical mastectomyBreast reconstruction
分类号:
R737.9
DOI:
10.3969/j.issn.1006-1959.2019.02.036
文献标志码:
A
摘要:
目的 研究背阔肌皮瓣联合假体在乳腺癌改良根治术后乳房重建中的应用。方法 选取2013年6月~2017年6月本院收治的100例乳腺癌患者作为研究对象,通过抓阄法随机分为对照组和观察组,每组50例,其中对照组采用传统治疗方式,观察组患者采用背阔肌皮瓣联合假体治疗方式,使用焦虑评价量表(ASA)评价患者焦虑情况,比较两组患者对体型、社交方面的满意度,复发、转移和生存情况。结果 观察组对术后焦虑情况、体型、社交方面的满意度分别为24.00%、50.00%、90.00%均优于对照组的86.00%、6.00%、2
Abstract:
Objective To study the application of latissimus dorsi flap combined with prosthesis in breast reconstruction after modified radical mastectomy. Methods 100 cases of breast cancer patients admitted to our hospital from June 2013 to June 2017 were randomly divided into control group and observation group, 50 cases in each group. The control group was treated with traditional treatment. Patients in the group were treated with latissimus dorsi flap combined with prosthesis. The anxiety assessment scale (ASA) was used to evaluate the anxiety of the patients. The satisfaction of body shape and social aspects, recurrence, metastasis and survival were compared between the two groups. Results The satisfaction degree of postoperative anxiety, body type and social aspects of the observation group were 24.00%, 50.00%, and 90.00%, respectively, which were better than 86.00%, 6.00%, and 26.00% of the control group,the difference was statistically significant (P<0.05). There was no local tumor recurrence in the observation group, and no pathological death occurred. One of the patients had bone metastasis at the 20th month after surgery. In the control group, 4 patients had distant metastases, 1 patient had only distant metastasis, 1 patient had local recurrence, and accompanied by distant metastasis. The remaining 1 patient had simple local recurrence and 2 patients died.There was no significant difference in the local recurrence and mortality between the two groups (P>0.05). Conclusion For patients with breast reconstruction after modified radical mastectomy for breast cancer, latissimus dorsi flap combined with prosthesis is used for clinical curative effect without increasing tumor recurrence and high patient satisfaction.

参考文献/References:

[1]刘国华.乳腺癌改良根治术后即刻背阔肌皮瓣乳房重建对女性乳腺癌患者术后自我效能感及生活质量的影响[J].河南医学研究,2017,26(14):2508-2510.
[2]刘洋.乳腺癌改良根治术后即刻背阔肌皮瓣乳房重建的临床疗效观察[J].医药论坛杂志,2016,37(11): 88-90.
[3]高印奇,方仪,杨雪,等.乳腺癌改良根治术与Ⅰ期重建术后生活质量的对比分析[J].中国肿瘤临床,2014,41(11):729-733.
[4]崔世恩,凌飞海,黄志华,等.保留乳头乳晕乳腺癌术后背阔肌皮瓣加假体一期置入乳房再造的临床分析[J].中国医药科学,2014,4(3):74-76.
[5]苏瑛,邵清,单海琳,等.乳腺癌改良根治术后背阔肌皮瓣联合假体一期乳房重建(附20例报告)[J].外科理论与实践,2014,19(5):422-426.

相似文献/References:

[1]董 云.SPECT/CT 双时相99mTc- MIBI断层显像 在乳腺癌诊断中的应用[J].医学信息,2018,31(05):147.[doi:10.3969/j.issn.1006-1959.2018.05.053]
 DONG Yun.Application of SPECT/CT Dual-phase 99mTc-MIBI Tomography in the Diagnosis of Breast Cancer[J].Journal of Medical Information,2018,31(02):147.[doi:10.3969/j.issn.1006-1959.2018.05.053]
[2]张 虎,张 涛,徐 芳,等.MRI在乳腺癌诊治中的研究进展[J].医学信息,2022,35(10):62.[doi:10.3969/j.issn.1006-1959.2022.10.015]
 ZHANG Hu,ZHANG Tao,XU Fang,et al.Research Progress of MRI in Diagnosis and Treatment of Breast Cancer[J].Journal of Medical Information,2022,35(02):62.[doi:10.3969/j.issn.1006-1959.2022.10.015]
[3]李建辉,祝旭龙.乳腺癌的治疗管理——把好生活质量关[J].医学信息,2018,31(13):1.[doi:10.3969/j.issn.1006-1959.2018.13.001]
[4]杨玉峰,李 强,曲国红,等.乳腺癌术前巴德枪穿刺检测ER、PR的临床研究[J].医学信息,2018,31(13):163.[doi:10.3969/j.issn.1006-1959.2018.13.050]
 YANG Yu-feng,LI Qiang,QU Guo-hong,et al.Clinical Study on Preoperative ER and PR Detection of Bard Gun Puncture in Breast Cancer[J].Journal of Medical Information,2018,31(02):163.[doi:10.3969/j.issn.1006-1959.2018.13.050]
[5]刘雪静,路 红,徐熠琳,等.乳腺影像与容积导航技术初步应用的临床分析[J].医学信息,2022,35(11):161.[doi:10.3969/j.issn.1006-1959.2022.11.043]
 LIU Xue-jing,LU Hong,XU Yi-lin,et al.Clinical Analysis of the Preliminary Application of Breast Imaging and Volume Navigation Technology[J].Journal of Medical Information,2022,35(02):161.[doi:10.3969/j.issn.1006-1959.2022.11.043]
[6]孟庆国,王佳雪,王斯佳.马来酸吡咯替尼对乳腺癌术后患者心脏功能的影响[J].医学信息,2019,32(02):152.[doi:10.3969/j.issn.1006-1959.2019.02.045]
 MENG Qing-guo,WANG Jia-xue,WANG Si-jia.Effect of Pyrrolidine Maleate on Cardiac Function in Patients after Breast Cancer Operation[J].Journal of Medical Information,2019,32(02):152.[doi:10.3969/j.issn.1006-1959.2019.02.045]
[7]刘 曼,厉玛倩倩,徐润润,等.延续性护理对乳腺癌术后化疗患者生活质量与 健康知识水平的影响[J].医学信息,2018,31(16):178.[doi:10.3969/j.issn.1006-1959.2018.16.057]
 LIU Man,LIMA Qian-qian,XU Run-run,et al.Effect of Continuous Nursing on Quality of Life and Health Knowledge of Postoperative Chemotherapy Patients with Breast Cancer[J].Journal of Medical Information,2018,31(02):178.[doi:10.3969/j.issn.1006-1959.2018.16.057]
[8]满枋霖,葛俊宏,林晓月,等.p21活化激酶在乳腺癌中的作用研究[J].医学信息,2019,32(06):35.[doi:10.3969/j.issn.1006-1959.2019.06.013]
 MAN Fang-lin,GE Jun-hong,LIN Xiao-yue,et al.The Role of p21 Activated Kinase in Breast Cancer[J].Journal of Medical Information,2019,32(02):35.[doi:10.3969/j.issn.1006-1959.2019.06.013]
[9]张天竺,宁 勇.长链非编码RNA调控乳腺癌发生发展的研究进展[J].医学信息,2019,32(12):40.[doi:10.3969/j.issn.1006-1959.2019.12.014]
 ZHANG Tian-zhu,NING Yong.Advances in Research on Long-chain Non-coding RNA Regulation of Breast Cancer Development[J].Journal of Medical Information,2019,32(02):40.[doi:10.3969/j.issn.1006-1959.2019.12.014]
[10]苏 晓.乳腺癌的靶向药物治疗[J].医学信息,2019,32(12):46.[doi:10.3969/j.issn.1006-1959.2019.12.015]
 SU Xiao.Targeted Drug Therapy for Breast Cancer[J].Journal of Medical Information,2019,32(02):46.[doi:10.3969/j.issn.1006-1959.2019.12.015]

更新日期/Last Update: 2019-02-15